Mavyretz Approved for Acute Hepatitis C; ALD Deaths Double; Entyvio in Pregnancy

By News Health
21 hours Ago

(MedPage Today) — The FDA expanded the approval of the direct-acting antiviral (DAA) glecaprevir/pibrentasvir (Mavyret), making it the first treatment for acute hepatitis C virus, AbbVie announced.
Compared with no treatment for chronic hepatitis…

Source link : https://www.medpagetoday.com/gastroenterology/generalgastroenterology/116048

Author :

Publish date : 2025-06-12 19:38:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Antipsychotic Adherence Linked With Lower Car Crash Risk

Medical Groups Urge Insurers to Cover COVID Shots in Pregnancy

MedPod Today: ACIP Firings; Goodbye, Benadryl? Practice-Changing ASCO Studies

FDA OKs Perioperative Immunotherapy for Head and Neck Cancer

AMA Opposes Estate Recovery to Recoup Medicaid $$ From Dead Beneficiaries

Is superintelligent AI just around the corner, or just a sci-fi dream?